Scihuhuan平台已收录预计检索 <10 秒
Oral Butyrate Reduces Progression of Kidney Damage in an L- NAME -Induced Diabetic Kidney Disease Mouse Model
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
- 题目
- Oral Butyrate Reduces Progression of Kidney Damage in an L- NAME -Induced Diabetic Kidney Disease Mouse Model
- 作者
- Maria Novella Nicese, Angela Koudijs, Reshma Lalai, Cristina Avramut, Rico J. E. Derks, Elena Sánchez‐López, Martin Giera, Amanda C. M. Pronk, Artemiy Kovynev, Sander Kooijman, Patrick C. N. Rensen, Roel Bijkerk, Bernard M. van den Berg, Joris I. Rotmans
- 发表年份
- 2026
- 期刊 / 来源
- Diabetes, Obesity and Metabolism
- 出版社
- Wiley
- 文献类型
- 学术文献
- 平台记录更新
- 2026-09-03 21:56:56
本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。
引用格式
同来源相关文献
Safety, Pharmacokinetics and Pharmacodynamics of the GLP -1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study2026 · Diabetes, Obesity and MetabolismHepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis2025 · Diabetes, Obesity and MetabolismJoint Trajectories of Physical Activity and Depressive Symptoms and Incident Cardiometabolic Multimorbidity: A Multi-Cohort Study2026 · Diabetes, Obesity and MetabolismImpact of caloric restriction on diabetes remission in Korean adults with obesity (CREDO-K study)2025 · Diabetes, Obesity and MetabolismOptimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food-intake reduction, Mediterranean diet, chrononutrition and physical training—The DIABEPIC -2 pilot study2025 · Diabetes, Obesity and MetabolismEfficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24-week, randomized, open-label, multicenter trial2026 · Diabetes, Obesity and Metabolism